Labixiaoxin Snacks Group Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Labixiaoxin Snacks Group te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Food winstgroei	13.4%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

We Discuss Why Labixiaoxin Snacks Group Limited's (HKG:1262) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Jun 11

Labixiaoxin Snacks Group Limited (HKG:1262) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

May 10

Labixiaoxin Snacks Group (HKG:1262) Is Experiencing Growth In Returns On Capital

Feb 01

There's Been No Shortage Of Growth Recently For Labixiaoxin Snacks Group's (HKG:1262) Returns On Capital

Oct 28

These 4 Measures Indicate That Labixiaoxin Snacks Group (HKG:1262) Is Using Debt Extensively

Sep 23

Labixiaoxin Snacks Group (HKG:1262) Shareholders Will Want The ROCE Trajectory To Continue

Apr 03

We Believe Labixiaoxin Snacks Group's (HKG:1262) Earnings Are A Poor Guide For Its Profitability

Oct 06

Is Labixiaoxin Snacks Group (HKG:1262) A Risky Investment?

Apr 01

How Should Investors React To Labixiaoxin Snacks Group's (HKG:1262) CEO Pay?

Dec 08

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Labixiaoxin Snacks Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

SEHK:1262 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	846	-144	0	37	N/A
3/31/2024	805	-124	28	63	N/A
12/31/2023	764	-105	55	89	N/A
9/30/2023	756	-90	63	99	N/A
6/30/2023	748	-75	71	110	N/A
3/31/2023	716	-75	33	63	N/A
12/31/2022	684	-75	-5	15	N/A
9/30/2022	660	-86	-20	-3	N/A
6/30/2022	635	-98	-35	-22	N/A
3/31/2022	642	-81	-96	-79	N/A
12/31/2021	648	-65	-157	-135	N/A
9/30/2021	634	5	-165	-147	N/A
6/30/2021	620	75	-174	-159	N/A
3/31/2021	564	23	-98	-86	N/A
12/31/2020	509	-29	-22	-12	N/A
9/30/2020	481	-109	-43	-33	N/A
6/30/2020	454	-189	-64	-53	N/A
3/31/2020	460	-179	-20	-9	N/A
12/31/2019	467	-170	24	35	N/A
9/30/2019	473	-177	64	77	N/A
6/30/2019	480	-185	104	119	N/A
3/31/2019	491	-182	89	104	N/A
12/31/2018	503	-180	74	89	N/A
9/30/2018	628	-234	-4	36	N/A
6/30/2018	754	-287	-83	-18	N/A
3/31/2018	828	-288	N/A	-43	N/A
12/31/2017	903	-289	N/A	-69	N/A
9/30/2017	908	-384	N/A	-1	N/A
6/30/2017	913	-478	N/A	67	N/A
3/31/2017	903	-540	N/A	-6	N/A
12/31/2016	893	-602	N/A	-78	N/A
9/30/2016	892	-566	N/A	-101	N/A
6/30/2016	891	-530	N/A	-124	N/A
3/31/2016	969	-434	N/A	-31	N/A
12/31/2015	1,047	-338	N/A	62	N/A
9/30/2015	1,066	-162	N/A	131	N/A
6/30/2015	1,085	15	N/A	200	N/A
3/31/2015	1,107	13	N/A	159	N/A
12/31/2014	1,129	11	N/A	118	N/A
9/30/2014	1,301	81	N/A	89	N/A
6/30/2014	1,473	150	N/A	60	N/A
3/31/2014	1,653	238	N/A	200	N/A
12/31/2013	1,834	326	N/A	341	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van 1262 boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van 1262 naar verwachting sneller zal groeien dan de markt Hong Kong

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van 1262 naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van 1262 naar verwachting sneller zal groeien dan de markt Hong Kong.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van 1262 naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van 1262 naar verwachting over 3 jaar hoog zal zijn

Labixiaoxin Snacks Group Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Labixiaoxin Snacks Group Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Labixiaoxin Snacks Group Limited Provides Unaudited Earnings Guidance for the Six Months Ended June 30, 2021

Labixiaoxin Snacks Group Limited Provides Group Earnings Guidance for the Year Ended 31 December 2020

Recent updates

First half 2024 earnings released: CN¥0.33 loss per share (vs CN¥0.036 loss in 1H 2023)

Labixiaoxin Snacks Group Limited to Report First Half, 2024 Results on Aug 29, 2024

New major risk - Shareholder dilution

New major risk - Market cap size

We Discuss Why Labixiaoxin Snacks Group Limited's (HKG:1262) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year

Labixiaoxin Snacks Group Limited (HKG:1262) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Labixiaoxin Snacks Group (HKG:1262) Using Too Much Debt?

Labixiaoxin Snacks Group Limited, Annual General Meeting, Jun 18, 2024

Full year 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.057 loss in FY 2022)

Labixiaoxin Snacks Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Share price stability

Is Labixiaoxin Snacks Group (HKG:1262) Weighed On By Its Debt Load?

A Look At The Fair Value Of Labixiaoxin Snacks Group Limited (HKG:1262)

First half 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.004 loss in 1H 2022)

Labixiaoxin Snacks Group Limited to Report First Half, 2023 Results on Aug 30, 2023

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.06 loss per share (vs CN¥0.049 loss in FY 2021)

Labixiaoxin Snacks Group (HKG:1262) Is Experiencing Growth In Returns On Capital

Less than half of directors are independent

There's Been No Shortage Of Growth Recently For Labixiaoxin Snacks Group's (HKG:1262) Returns On Capital

These 4 Measures Indicate That Labixiaoxin Snacks Group (HKG:1262) Is Using Debt Extensively

Labixiaoxin Snacks Group Limited Announces Board and Committee Changes

First half 2022 earnings released: CN¥0.004 loss per share (vs CN¥0.021 profit in 1H 2021)

Labixiaoxin Snacks Group Limited to Report First Half, 2022 Results on Aug 29, 2022

Labixiaoxin Snacks Group Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

Full year 2021 earnings released: CN¥0.049 loss per share (vs CN¥0.022 loss in FY 2020)

Labixiaoxin Snacks Group Limited, Annual General Meeting, Jun 23, 2022

Less than half of directors are independent

Labixiaoxin Snacks Group (HKG:1262) Shareholders Will Want The ROCE Trajectory To Continue

Full year 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.022 loss in FY 2020)

We Believe Labixiaoxin Snacks Group's (HKG:1262) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS CN¥0.021 (vs CN¥0.058 loss in 1H 2020)

Labixiaoxin Snacks Group Limited Provides Unaudited Earnings Guidance for the Six Months Ended June 30, 2021

Full year 2020 earnings released: CN¥0.02 loss per share (vs CN¥0.13 loss in FY 2019)

Is Labixiaoxin Snacks Group (HKG:1262) A Risky Investment?

Labixiaoxin Snacks Group Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Labixiaoxin Snacks Group Limited Provides Group Earnings Guidance for the Year Ended 31 December 2020

New 90-day low: HK$0.24

How Should Investors React To Labixiaoxin Snacks Group's (HKG:1262) CEO Pay?

New 90-day low: HK$0.26

First half earnings released

New 90-day low - HK$0.27

First half earnings released

New 90-day low - HK$0.31

Labixiaoxin Snacks Group Limited to Report First Half, 2020 Results on Aug 31, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven